All Stories

  1. GERPAC Consensus Conference – Guidance on the Assignment of Microbiological Shelf-life for Hospital Pharmacy Aseptic Preparations

    Article • Pharmaceutical Technology in Hospital Pharmacy, May 2020, De Gruyter

    frederic Lagarce, Paul Le Brun, Professor Jean-Daniel HECQ, Alison Beaney

  2. Methods for the Study of Physical and Chemical Stability and Container-Content Interactions: Report of a GERPAC Workshop

    Article • Pharmaceutical Technology in Hospital Pharmacy, June 2019, De Gruyter

    frederic Lagarce

  3. The Art of Compounding in Hospital Pharmacy

    Article • Pharmaceutical Technology in Hospital Pharmacy, June 2019, De Gruyter

    frederic Lagarce

  4. Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity

    Article • International Journal of Nanomedicine, March 2019, Dove Medical Press

    frederic Lagarce

  5. The Importance of a Scientific Journal in the Field of Pharmaceutical Technology in Hospitals

    Article • Pharmaceutical Technology in Hospital Pharmacy, March 2019, De Gruyter

    frederic Lagarce

  6. Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation

    Article • Pharmaceutical Technology in Hospital Pharmacy, November 2018, De Gruyter

    frederic Lagarce

  7. Pharmaceutical Technology to Improve Patient Care

    Article • Pharmaceutical Technology in Hospital Pharmacy, November 2018, De Gruyter

    frederic Lagarce

  8. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models

    Article • Nanomedicine, September 2018, Future Medicine

    frederic Lagarce

  9. After Ten Issues Our Journal Has Found Its Audience and Main Topics

    Article • Pharmaceutical Technology in Hospital Pharmacy, July 2018, De Gruyter

    frederic Lagarce

  10. Quality in Stability Testing

    Article • Pharmaceutical Technology in Hospital Pharmacy, March 2018, De Gruyter

    frederic Lagarce

  11. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats

    Article • International Journal of Nanomedicine, November 2017, Dove Medical Press

    frederic Lagarce

  12. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

    Article • International Journal of Nanomedicine, November 2017, Dove Medical Press

    frederic Lagarce

  13. Centrally Prepared Cytotoxic Drugs: What Is the Purpose of Their Quality Control?

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2017, De Gruyter

    frederic Lagarce

  14. A special issue dedicated to the GERPAC 2016 meeting

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2017, De Gruyter

    frederic Lagarce

  15. Quality Assurance in Hospital Pharmacy Compounding Units is a Multi Player Game

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2017, De Gruyter

    frederic Lagarce

  16. A New Journal in the Field of Pharmaceutical Technology Is Born

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2016, De Gruyter

    frederic Lagarce

  17. The Field of Pharmaceutical Technology in Hospitals is Broad

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2016, De Gruyter

    frederic Lagarce

  18. PTHP’s First Special Issue on Chemical Contamination

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2016, De Gruyter

    frederic Lagarce

  19. Quality and Safety in the Hospital: The Pharmacist is the Key Person

    Article • Pharmaceutical Technology in Hospital Pharmacy, January 2016, De Gruyter

    frederic Lagarce

  20. Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide

    Article • European Journal of Nanomedicine, January 2015, De Gruyter

    frederic Lagarce

  21. Is the translational approach becoming a reality in nanomedicine?

    Article • European Journal of Nanomedicine, January 2015, De Gruyter

    frederic Lagarce

  22. Nanomedicines: are we lost in translation?

    Article • European Journal of Nanomedicine, January 2015, De Gruyter

    frederic Lagarce

  23. Mucus models to evaluate nanomedicines for diffusion

    Article • Drug Discovery Today, August 2014, Elsevier

    frederic Lagarce

  24. Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide

    Article • International Journal of Nanomedicine, March 2014, Taylor & Francis

    frederic Lagarce

  25. Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution

    Article • Journal of Pharmaceutical and Biomedical Analysis, March 2014, Elsevier

    frederic Lagarce

  26. PP-003 Physical-chemical stability of docetaxel concentrated solution during one month

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    frederic Lagarce

  27. Development of 2D and 3D Mucus Models and Their Interactions with Mucus-Penetrating Paclitaxel-Loaded Lipid Nanocapsules

    Article • Pharmaceutical Research, January 2014, Springer Science + Business Media

    frederic Lagarce

  28. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery

    Article • International Journal of Nanomedicine, November 2013, Taylor & Francis

    frederic Lagarce

  29. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide

    Article • European Journal of Pharmaceutical Sciences, October 2013, Elsevier

    frederic Lagarce

  30. Nanoparticle Therapies for Wounds and Ulcer Healing

    Article • June 2013, Taylor & Francis

    frederic Lagarce

  31. Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study

    Article • International Journal of Nanomedicine, November 2011, Taylor & Francis

    frederic Lagarce

  32. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2011, Elsevier

    frederic Lagarce

  33. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells

    Article • European Journal of Pharmaceutical Sciences, August 2010, Elsevier

    frederic Lagarce

  34. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery

    Article • Nanomedicine, February 2010, Future Medicine

    frederic Lagarce

  35. Toxicological Study and Efficacy of Blank and Paclitaxel-Loaded Lipid Nanocapsules After i.v. Administration in Mice

    Article • Pharmaceutical Research, January 2010, Springer Science + Business Media

    frederic Lagarce

  36. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis

    Article • Journal of Controlled Release, December 2009, Elsevier

    frederic Lagarce

  37. Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2009, Elsevier

    frederic Lagarce

  38. The gastrointestinal stability of lipid nanocapsules

    Article • International Journal of Pharmaceutics, September 2009, Elsevier

    frederic Lagarce

  39. The adaptation of lipid nanocapsule formulations for blood administration in animals

    Article • International Journal of Pharmaceutics, September 2009, Elsevier

    frederic Lagarce

  40. 1208 Toxicity of systemic administration of blank and paclitaxel-loaded lipid nanocapsules in mice

    Article • European Journal of Cancer Supplements, September 2009, Elsevier

    frederic Lagarce

  41. Efficacité anti-tumorale et tolérance du paclitaxel vectorisé dans des nanocapsules lipidiques versus Taxol® par voie intraveineuse dans un modèle de tumeur sous-cutanée NCI-H460

    Article • Revue des Maladies Respiratoires, November 2008, Elsevier

    frederic Lagarce

  42. Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules

    Article • Pharmaceutical Research, May 2006, Springer Science + Business Media

    frederic Lagarce

  43. Development and characterization of interleukin-18-loaded biodegradable microspheres

    Article • International Journal of Pharmaceutics, May 2006, Elsevier

    frederic Lagarce

  44. Development of new polymer-based particulate systems for anti-glioma vaccination

    Article • International Journal of Pharmaceutics, February 2006, Elsevier

    frederic Lagarce

  45. Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: In vitro and in vivo evaluation

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2005, Elsevier

    frederic Lagarce

  46. Biopharmaceutics of intrathecal baclofen-loaded microparticles in a goat model

    Article • International Journal of Pharmaceutics, July 2005, Elsevier

    frederic Lagarce

  47. Baclofen-loaded microspheres: preparation and efficacy testing in a new rabbit model

    Article • European Journal of Pharmaceutics and Biopharmaceutics, April 2005, Elsevier

    frederic Lagarce

  48. Oxaliplatin loaded PLAGA microspheres:

    Article • International Journal of Pharmaceutics, August 2002, Elsevier

    frederic Lagarce